This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sylvester Sterioff, MD; Horst Zincke, MD; Wayne C. Waltzer, MD; S. Breanndan Moore, MD; Peter P. Frohnert, MD; Kenneth P. Offord, MS

Arch Surg. 1981;116(1):73-77.

Abstract
• A five-year retrospective analysis of patient and graft survival after initial cadaveric kidney transplantation showed that recipients of kidneys from cadaveric donors pretreated with cyclophosphamide (Cytoxan) and methylprednisolone (Medrol) had better graft survival than those patients who received nonpretreated kidneys. In patients not receiving transfusions, transplantation of a pretreated kidney improved the chances of success, with graft survival equivalent to that for patients receiving transfusions. Splenectomy was beneficial for graft survival and did not affect overall patient survival. The effect of splenectomy could not be clearly separated from the effect of donor pretreatment.

(Arch Surg 116:73-77, 1981)

Author Affiliations
From the Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Accepted for publication June 19, 1980.

Reprint requests to Section of General Surgery, Mayo Clinic, Rochester, MN 55901 (Dr Sterioff).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Primary and Secondary Renal Transplantation in Diabetic Patients
Okiye et al.
JAMA 1983;249:492-495.
ABSTRACT